Lionel F. Conacher
CIK 1417326 · Interim CEO · last filed 2026-05-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$253.3K
Companies
3
Total Filings
50
Lifetime Open-Market Net
$300.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DXLG | Director | 408,568 | $0.62 | $253.3K | $165.2K | 24 | 2026-05-06 |
| SRx Health Solutions, Inc. (BTTR) Delisted | Interim CEO | 37,232 | $2.12 | $78.9K | $265.9K | 10 | 2024-12-26 |
| Thomas Weisel Partners Group, Inc. (TWPG) Delisted | President and COO | 639,827 | — | — | -$130.2K | 15 | 2010-03-10 |
Recent Filings · Page 2 of 5
50 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-01 | SRx Health Solutions, Inc. (BTTR) Delisted | Grant (A) | +18,021 | $0 | EDGAR |
| 2023-01-05 | SRx Health Solutions, Inc. (BTTR) Delisted | Grant (A) | +178,572 | $100.0K | EDGAR |
| 2023-01-04 | SRx Health Solutions, Inc. (BTTR) Delisted | Grant (A) | +24,738 | $13.3K | EDGAR |
| 2022-11-04 | SRx Health Solutions, Inc. (BTTR) Delisted | Grant (A) | +40,817 | $40.0K | EDGAR |
| 2022-02-03 | SRx Health Solutions, Inc. (BTTR) Delisted | Grant (A) | +43,669 | $100.0K | EDGAR |
| 2021-11-16 | SRx Health Solutions, Inc. (BTTR) Delisted | Buy (P) | +10,000 | $39.6K | EDGAR |
| 2021-11-03 | DXLG | Grant (A) | +2,510 | $18.7K | EDGAR |
| 2021-08-04 | DXLG | Grant (A) | +3,742 | $18.7K | EDGAR |
| 2021-05-05 | DXLG | Other (J) | +12,096 | $18.7K | EDGAR |
| 2021-03-23 | DXLG | Buy (P) | +50,000 | $45.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.